High Prevalence of Normal Tests Assessing Hypercortisolism in Subjects with Mild and Episodic Cushing's Syndrome Suggests that the Paradigm for Diagnosis and Exclusion of Cushing's Syndrome Requires Multiple Testing

Abstract

Many Endocrinologists believe that a single determination of eucortisolism or a single demonstration of appropriate suppression to dexamethasone excluded Cushing's syndrome, except in what was previously thought to be the rare patient with episodic or periodic Cushing's syndrome. We hypothesize that episodic Cushing's syndrome is relatively common and a single test assessing hypercortisolism may not be sufficient to accurately rule out or diagnose Cushing's syndrome and retrospectively examined the number of normal and abnormal tests assessing hypercortisolism performed on multiple occasions in 66 patients found to have mild and/or episodic Cushing's syndrome compared to a similar group of 54 patients evaluated for, but determined not to have Cushing's syndrome. We found that 65 of the 66 patients with Cushing's syndrome had at least one normal test of cortisol status and most patients had several normal tests. The probability of having Cushing's syndrome when one test was negative was 92% for 23:00 h salivary cortisol, 88% for 24-h UFC, 86% for 24-h 17OHS, and 54% for nighttime plasma cortisol. These results demonstrated that episodic hypercortisolism is highly prevalent in subjects with mild Cushing's syndrome and no single test was effective in conclusively diagnosing or excluding the condition. Rather, the paradigm for the diagnosis should be a careful history and physical examination and in those patients in whom mild Cushing's syndrome/disease is strongly suspected, multiple tests assessing hypercortisolism should be performed on subsequent occasions, especially when the patient is experiencing signs and symptoms of short-term hypercortisolism.

Key words

Cushing's syndrome - episodic - periodic - urinary free cortisol - salivary cortisol - cortisol-binding globulin - 17-hydroxycorticosteroids

References

• 1 Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.  Endocr Rev. 1998;  19 647-672
• 2 Kidambi S, Raff H, Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.  Eur J Endocrinol. 2007;  157 725-731
• 3 Mantero F, Scaroni CM, Albiger NM. Cyclic Cushing's syndrome: an overview.  Pituitary. 2004;  7 203-207
• 4 Velez DA, Mayberg MR, Ludlam WH. Cyclic Cushing syndrome: definitions and treatment implications.  Neurosurg Focus. 2007;  23 E4; discussion E4a
• 5 Meinardi JR, Wolffenbuttel BH, Dullaart RP. Cyclic Cushing's syndrome: a clinical challenge.  Eur J Endocrinol. 2007;  157 245-254
• 6 Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2008;  93 1526-1540
• 7 Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement.  J Clin Endocrinol Metab. 2003;  88 5593-5602
• 8 Crapo LM. Cushing's syndrome: a review of diagnostic tests.  Metab. 1979;  28 955-977
• 9 Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome.  Endocrinol Metab Clin North Am. 2001;  30 729-747
• 10 Kaye TB, Crapo L. The Cushing syndrome: An update on diagnostic tests.  Ann Intern Med. 1990;  112 434-444
• 11 Meier CA, Biller BM. Clinical and biochemical evaluation of Cushing's syndrome.  Endocrinol Metab Clin North Am. 1997;  26 741-762
• 12 Nieman LK. Cushing's syndrome.  Curr Ther Endocrinol Metab. 1997;  6 161-164
• 13 Orth DN. Cushing's syndrome.  N Engl J Med. 1995;  332 791-803
• 14 Ross RJ, Trainer PJ. Endocrine investigation: Cushing's syndrome.  Clin Endocrinol. 1998;  49 153-155
• 15 Friedman TC. Pseudo-Cushing syndrome.. In: Margioris AN, Chrousos GP, (eds) Contemporary Endocrinology: Adrenal Disorders. Totowa, NJ: Humana Press; 2001: 203-218
• 16 Pall ME, Lao MC, Patel SS, Lee ML, Ghods DE, Chandler DW, Friedman TC. Testosterone and Bioavailable Testosterone Help to Distinguish between Mild Cushing's Syndrome and Polycystic Ovarian Syndrome.  Horm Metab Res. 2008;  40 813-818
• 17 Burke CW. Biologically active cortisol in plasma of oestrogen-treated and normal subjects.  Br Med J. 1969;  2 798-800
• 18 Doe RP, Zinneman HH, Flink HB, Ulstrom RA. Significance of the concentration of non protein bound plasma cortisol in normal subjects, Cushing's syndrome, pregnancy and during estrogen therapy.  J Clin Endocrinol Metab. 1960;  20 1484-1492
• 19 Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler Jr GB, Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.  N Engl J Med. 1991;  325 897-905
• 20  . Esoterix Directory of Services.  2004;  136
• 21 Foster LB, Dunn RT. Single-antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma.  Clin Chem. 1974;  20 365-368
• 22 Papanicolaou DA, Yanovski JA, Cutler Jr G, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.  J Clin Endocrinol Metab. 1998;  83 1163-1167
• 23 Raff H, Homar PJ, Skoner DP. New enzyme immunoassay for salivary cortisol.  Clin Chem. 2003;  49 203-204
• 24 Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome.  J Clin Endocrinol Metab. 1998;  83 2681-2686
• 25  . Esoterix Directory of Services. 135.  2004;  135
• 26 Van Herle AJ, Birnbaum JA, Slomowitz LA, Mayes D, Chandler DW, Rosenblit PD, Nissenson A. Paper chromatography prior to cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure.  Nephron. 1998;  80 79-84
• 27 Boscaro M, Arnaldi G. Approach to the patient with possible Cushing's syndrome.  J Clin Endocrinol Metab. 2009;  94 3121-3131
• 28 . Esoterix Directory of Services.  2004;  239
• 29 Silber RH, Porter CC. The determination of 17, 21-dihydroxy-20-ketosteroids in urine and plasma.  J Biol Chem. 1954;  210 923-932
• 30 Clopper CJ, Pearson E. The use of confidence or fiducial limits illustrated in the case of binomial.  Biometrika. 1934;  26 404-413
• 31 McNemar Q. Note on the sampling error of the differences between correlated proportions or percentages.  Psycometrika. 1947;  12 153-157
• 32 McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.  Clin Endocrinol (Oxf). 1993;  38 79-86
• 33 Streeten DH, Anderson Jr GH, Dalakos T, Joachimpillai AD. Intermittent hypercortisolism: a disorder strikingly prevalent after hypophysial surgical procedures.  Endocr Pract. 1997;  3 123-129
• 34 Atkinson AB, Kennedy AL, Carson DJ, Hadden DR, Weaver JA, Sheridan B. Five cases of cyclical Cushing's syndrome.  Br Med J (Clin Res Ed). 1985;  291 1453-1457
• 35 Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.  J Clin Endocrinol Metab. 2009;  94 456-462
• 36 Mengden T, Hubman P, Muller J, Greminger P, Vetter W. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.  Clin Investig. 1992;  70 545-548
• 37 Friedman TC. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.  Exp Clin Endocrinol Diabetes. 2006;  114 356-360
• 38 Kruse A, Klinken L, Holck S, Lindholm J. Pituitary histology in Cushing's disease.  Clin Endocrinol (Oxf). 1992;  37 254-259
• 39 Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors.  J Neurosurg. 2006;  104 7-19
• 40 Meeran K, Hattersley A, Mould G, Bloom SR. Venepuncture causes rapid rise in plasma ACTH.  Br J Clin Pract. 1993;  47 246-247
• 41 Patel PM, Shahinian H, Friedman TC. Cushing's disease is not necessarily a progressive and fatal disease: A case of documented Cushing's disease untreated for 26 years.  Endocrinologist. 2005;  15 343-344
• 42 Gabrilove JL. The continuum of adrenocortical disease: a thesis and its lesson to medicine.  J Mt Sinai Hosp NY. 1965;  32 634-636

Correspondence